Welcome to our dedicated page for Gohealth SEC filings (Ticker: GOCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how GoHealth (GOCO) navigates changing Medicare rules means wading through hundreds of pages of SEC disclosures. Finding policy-persistency metrics in a 10-K or spotting when executives unload shares via Form 4 can feel impossible.
Stock Titan’s AI solves that problem in seconds. Our platform streams every filing to your dashboard the instant it hits EDGAR, then delivers plain-English summaries that translate actuarial jargon and CMS references into clear business drivers. Whether you need GoHealth insider trading Form 4 transactions, a quick read-through of the GoHealth annual report 10-K simplified, or an alert on the latest GoHealth 8-K material events explained, everything is here—already tagged, indexed, and searchable.
Investors typically dig into three core areas:
- Customer economics: Our AI highlights acquisition cost trends buried deep in the quarterly earnings report 10-Q filing.
- Regulatory risk: Material event 8-Ks flag CMS policy shifts practically in real time, so you can act before the market digests them.
- Management signals: Follow GoHealth executive stock transactions Form 4 and board-level compensation details in the proxy statement without combing through appendices.
Stop scrolling endless PDFs. Stock Titan provides comprehensive coverage—Form S-8s, 424Bs, even the niche N-CSR—plus AI-powered cross-links that answer natural-language questions like “understanding GoHealth SEC documents with AI” or “GoHealth earnings report filing analysis.” Make informed decisions faster with expert context and real-time data.
GoHealth (Nasdaq: GOCO) filed an 8-K disclosing the results of its 2025 Annual Meeting of Stockholders held on June 18, 2025.
Shareholders elected three Class II directors—Brandon M. Cruz (17,218,021 FOR), Alan Wheatley (17,932,740 FOR) and Abhiraj R. Modi (17,619,537 FOR)—to serve until the 2028 meeting. Ernst & Young LLP was ratified as independent auditor with 21,544,738 FOR and only 557,922 AGAINST. The non-binding say-on-pay resolution passed (17,026,293 FOR; 992,227 AGAINST), and shareholders approved an amendment to the 2020 Incentive Award Plan (16,755,619 FOR; 1,287,341 AGAINST).
No financial performance metrics, strategic updates, or other material events were included in the filing.